Myomo https://myomo.com/ The MyoPro Brace for Stroke Survivor's Paralyzed Arm Mon, 20 Apr 2026 20:07:58 +0000 en-US hourly 1 https://wordpress.org/?v=6.9.4 https://myomo.com/wp-content/uploads/2025/01/cropped-Untitled-design-25-32x32.png Myomo https://myomo.com/ 32 32 Myomo Introduces Myomo Mobile App to Enhance Clinical Workflow and Patient Engagement https://myomo.com/myomo-introduces-myomo-mobile-app-to-enhance-clinical-workflow-and-patient-engagement/ https://myomo.com/myomo-introduces-myomo-mobile-app-to-enhance-clinical-workflow-and-patient-engagement/#respond Mon, 20 Apr 2026 20:07:58 +0000 https://myomo.com/?p=5021495 BURLINGTON, Mass. — April 20, 2026 — Myomo, Inc. (NYSE American: MYO), a wearable medical robotics company that offers increased functionality for people with neurological disorders and upper-limb paralysis, announces the launch of the Myomo® Mobile App, a new digital tool designed to support clinicians and patients throughout the MyoPro® experience. The Myomo Mobile App is […]

The post Myomo Introduces Myomo Mobile App to Enhance Clinical Workflow and Patient Engagement appeared first on Myomo.

]]> BURLINGTON, Mass. — April 20, 2026 — Myomo, Inc. (NYSE American: MYO), a wearable medical robotics company that offers increased functionality for people with neurological disorders and upper-limb paralysis, announces the launch of the Myomo® Mobile App, a new digital tool designed to support clinicians and patients throughout the MyoPro® experience.

The Myomo Mobile App is designed to make MyoPro care more intuitive, more connected, and more data-informed. For clinicians, the app provides a streamlined mobile interface for customizing EMG settings in person or remotely, including gain, threshold, range of motion, and advanced settings. It also gives clinicians visibility into patient usage and device configurations, helping support more proactive follow-up and care management. Read more.

The post Myomo Introduces Myomo Mobile App to Enhance Clinical Workflow and Patient Engagement appeared first on Myomo.

]]> https://myomo.com/myomo-introduces-myomo-mobile-app-to-enhance-clinical-workflow-and-patient-engagement/feed/ 0 Myomo Appoints William J Febbo to its Board of Directors https://myomo.com/myomo-appoints-william-j-febbo-to-its-board-of-directors/ https://myomo.com/myomo-appoints-william-j-febbo-to-its-board-of-directors/#respond Thu, 16 Apr 2026 20:05:22 +0000 https://myomo.com/?p=5021492 BURLINGTON, MA. (April 16, 2026) – Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today announced the appointment of William “Will” Febbo as a director effective April 14, 2026, to serve until the 2028 annual meeting […]

The post Myomo Appoints William J Febbo to its Board of Directors appeared first on Myomo.

]]> BURLINGTON, MA. (April 16, 2026) – Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today announced the appointment of William “Will” Febbo as a director effective April 14, 2026, to serve until the 2028 annual meeting of stockholders. With this appointment, Myomo has six directors.

Mr. Febbo is an accomplished executive, entrepreneur, and investor with over 30 years of experience in healthcare, financial services, and technology-driven businesses. He has successfully guided organizations through substantial growth, strategic transformations and acquisitions, and significant capital markets initiatives. Read more.

The post Myomo Appoints William J Febbo to its Board of Directors appeared first on Myomo.

]]> https://myomo.com/myomo-appoints-william-j-febbo-to-its-board-of-directors/feed/ 0 Myomo and Elevance Health Agree to Contract for Multi-State Network Participation https://myomo.com/myomo-and-elevance-health-agree-to-contract-for-multi-state-network-participation/ https://myomo.com/myomo-and-elevance-health-agree-to-contract-for-multi-state-network-participation/#respond Mon, 09 Mar 2026 20:15:59 +0000 https://myomo.com/?p=5021184 BURLINGTON, Mass. (March 9, 2026) – Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, announced today it has entered into its first among a series of expected network participation agreements with Elevance Health.  The contracts, which include […]

The post Myomo and Elevance Health Agree to Contract for Multi-State Network Participation appeared first on Myomo.

]]> BURLINGTON, Mass. (March 9, 2026) – Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, announced today it has entered into its first among a series of expected network participation agreements with Elevance Health.  The contracts, which include the Anthem-affiliated Commercial, Medicare Advantage, and Medicaid plans are expected to become effective on a market-by-market basis through the second quarter of 2026.  Once complete, the addition of these 45 million medical members will bring Myomo’s total number of covered lives under commercial insurance plans to over 80 million. Read more.

The post Myomo and Elevance Health Agree to Contract for Multi-State Network Participation appeared first on Myomo.

]]> https://myomo.com/myomo-and-elevance-health-agree-to-contract-for-multi-state-network-participation/feed/ 0 Myomo Reports Fourth Quarter and Full Year 2025 Financial and Operating Results https://myomo.com/myomo-reports-fourth-quarter-and-full-year-2025-financial-and-operating-results/ https://myomo.com/myomo-reports-fourth-quarter-and-full-year-2025-financial-and-operating-results/#respond Mon, 09 Mar 2026 20:14:34 +0000 https://myomo.com/?p=5021181 Fourth quarter revenue of $11.4 million, full year revenue of $40.9 million 42% of fourth quarter revenue from recurring patient sources  Record 241 authorizations and orders in the quarter   Introduces 2026 revenue guidance of $43 million to $46 million as Company emphasizes recurring sources of revenue   Conference call begins today at 4:30pm Eastern […]

The post Myomo Reports Fourth Quarter and Full Year 2025 Financial and Operating Results appeared first on Myomo.

]]> Fourth quarter revenue of $11.4 million, full year revenue of $40.9 million

42% of fourth quarter revenue from recurring patient sources

 Record 241 authorizations and orders in the quarter

  Introduces 2026 revenue guidance of $43 million to $46 million as Company emphasizes recurring sources of revenue

 

Conference call begins today at 4:30pm Eastern time

 

BURLINGTON, Mass. (March 9, 2026) – Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today reported financial results for the three months and year ended December 31, 2025.

“We delivered 2025 revenue at the midpoint of our updated guidance range with record fourth quarter revenues from the U.S. orthotics and prosthetics (“O&P”) and International sales channels.  We also achieved our strongest quarter of the year for MyoPro authorizations and orders,” said Paul Gudonis, Myomo’s Chairman and Chief Executive Officer.  “We look forward to improved results from our 2026 marketing initiatives as we place greater emphasis on referrals and other recurring patient sources with a lower customer acquisition cost.” Read more.

The post Myomo Reports Fourth Quarter and Full Year 2025 Financial and Operating Results appeared first on Myomo.

]]> https://myomo.com/myomo-reports-fourth-quarter-and-full-year-2025-financial-and-operating-results/feed/ 0 Myomo to Report Fourth Quarter 2025 Financial Results on March 9 https://myomo.com/myomo-to-report-fourth-quarter-2025-financial-results-on-march-9/ https://myomo.com/myomo-to-report-fourth-quarter-2025-financial-results-on-march-9/#respond Mon, 02 Mar 2026 21:10:11 +0000 https://myomo.com/?p=5021152 BURLINGTON, Mass. (March 2, 2026) – Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today announced that it will report financial results for the fourth quarter and year ended December 31, 2025 on Monday, March 9, […]

The post Myomo to Report Fourth Quarter 2025 Financial Results on March 9 appeared first on Myomo.

]]> BURLINGTON, Mass. (March 2, 2026) – Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today announced that it will report financial results for the fourth quarter and year ended December 31, 2025 on Monday, March 9, 2026.  Management will hold a conference call beginning at 4:30 p.m. Eastern time to review the results, provide a business update and answer questions. Read More.

The post Myomo to Report Fourth Quarter 2025 Financial Results on March 9 appeared first on Myomo.

]]> https://myomo.com/myomo-to-report-fourth-quarter-2025-financial-results-on-march-9/feed/ 0 Myomo Reports Third Quarter 2025 Financial and Operating Results https://myomo.com/myomo-reports-third-quarter-2025-financial-and-operating-results/ https://myomo.com/myomo-reports-third-quarter-2025-financial-and-operating-results/#respond Mon, 10 Nov 2025 21:05:25 +0000 https://myomo.com/?p=5020863 Revenue of $10.1 million 229 authorizations and orders, highest number this year Reiterates full year revenue guidance of $40 million to $42 million   Conference call begins today at 4:30pm Eastern time   BURLINGTON, Mass. (November 10, 2025) – Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers […]

The post Myomo Reports Third Quarter 2025 Financial and Operating Results appeared first on Myomo.

]]> Revenue of $10.1 million

229 authorizations and orders, highest number this year

Reiterates full year revenue guidance of $40 million to $42 million

 

Conference call begins today at 4:30pm Eastern time

 

BURLINGTON, Mass. (November 10, 2025) – Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today reported financial results for the three and nine months ended September 30, 2025. Read more.

The post Myomo Reports Third Quarter 2025 Financial and Operating Results appeared first on Myomo.

]]> https://myomo.com/myomo-reports-third-quarter-2025-financial-and-operating-results/feed/ 0 Myomo to Report Third Quarter 2025 Financial Results on November 10 https://myomo.com/myomo-to-report-third-quarter-2025-financial-results-on-november-10/ https://myomo.com/myomo-to-report-third-quarter-2025-financial-results-on-november-10/#respond Mon, 03 Nov 2025 21:15:20 +0000 https://myomo.com/?p=5020852 BURLINGTON, Mass. (November 3, 2025) – Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today announced that it will report financial results for the third quarter of 2025 on Monday, November 10, 2025.  Management will hold […]

The post Myomo to Report Third Quarter 2025 Financial Results on November 10 appeared first on Myomo.

]]> BURLINGTON, Mass. (November 3, 2025) – Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today announced that it will report financial results for the third quarter of 2025 on Monday, November 10, 2025.  Management will hold a conference call beginning at 4:30 p.m. Eastern time to review the results, provide a business update and answer questions. Read more.

The post Myomo to Report Third Quarter 2025 Financial Results on November 10 appeared first on Myomo.

]]> https://myomo.com/myomo-to-report-third-quarter-2025-financial-results-on-november-10/feed/ 0 Myomo at H.C. Wainwright 27th Global Conference https://myomo.com/myomo-to-present-at-the-h-c-wainwright-27th-annual-global-investment-conference/ https://myomo.com/myomo-to-present-at-the-h-c-wainwright-27th-annual-global-investment-conference/#respond Tue, 02 Sep 2025 20:30:54 +0000 https://myomo.com/?p=5020803 BURLINGTON, Mass. (September 2, 2025) – Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today announced that Paul Gudonis, president and chief executive officer, and David Henry, chief financial officer, will present at the H.C. Wainwright […]

The post Myomo at H.C. Wainwright 27th Global Conference appeared first on Myomo.

]]> BURLINGTON, Mass. (September 2, 2025) – Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today announced that Paul Gudonis, president and chief executive officer, and David Henry, chief financial officer, will present at the H.C. Wainwright 27th Annual Global Investment Conference taking place September 8-10, 2025 at the Lotte New York Palace Hotel. A Company presentation will be available on demand for conference participants and management will be available for virtual one-on-one meetings with investors registered for the event. Read More.

The post Myomo at H.C. Wainwright 27th Global Conference appeared first on Myomo.

]]> https://myomo.com/myomo-to-present-at-the-h-c-wainwright-27th-annual-global-investment-conference/feed/ 0 Webinars https://myomo.com/webinars/ https://myomo.com/webinars/#respond Tue, 02 Sep 2025 19:31:41 +0000 https://myomo.com/?p=5020792 Myomo Webinar Series Stay Informed. Stay Connected. Stay Ahead. Join us for an exclusive three-part webinar series designed to equip clinicians, providers, and industry partners with the knowledge and tools to maximize the benefits of the MyoPro® 2x. Each session dives into a critical area to help you succeed—whether it’s navigating reimbursement, discovering what’s new, […]

The post Webinars appeared first on Myomo.

]]>

Myomo Webinar Series

Stay Informed. Stay Connected. Stay Ahead.

Join us for an exclusive three-part webinar series designed to equip clinicians, providers, and industry partners with the knowledge and tools to maximize the benefits of the MyoPro® 2x. Each session dives into a critical area to help you succeed—whether it’s navigating reimbursement, discovering what’s new, or strengthening collaboration with our partners.

Webinar 1: Reimbursement

Simplifying the Path to Patient Access
Learn the latest updates and best practices for securing reimbursement for MyoPro® devices. We’ll cover practical tips, documentation essentials, and resources designed to help you streamline the approval process so more patients can access the care they need.

Webinar 2: What’s New About the MyoPro® 2x

Next-Generation Innovation in Action
Discover the advanced features of the MyoPro® 2x and see how it’s setting new standards in usability and performance. We’ll explore product enhancements, patient benefits, and clinical applications that make the MyoPro 2x more powerful and effective than ever.

Webinar 3: Support for Our Industry Partners

Stronger Together
This session is dedicated to our valued partners. Learn how Myomo supports you with training, marketing tools, and patient engagement resources. We’ll also share strategies to strengthen collaboration and drive impact across the rehabilitation industry.

Reserve Your Spot

Choose one, two, or all three webinars—whatever fits your needs best. Don’t miss these opportunities to expand your expertise and better serve your patients and community.

Register Now

The post Webinars appeared first on Myomo.

]]> https://myomo.com/webinars/feed/ 0 Myomo Reports Second Quarter 2025 Financial and Operating Results https://myomo.com/myomo-reports-second-quarter-2025-financial-and-operating-results/ https://myomo.com/myomo-reports-second-quarter-2025-financial-and-operating-results/#respond Mon, 11 Aug 2025 20:10:56 +0000 https://myomo.com/?p=5020743 Myomo Reports Second Quarter 2025 Financial and Operating Results   Revenue of $9.7 million  816 patients added to the MyoPro pipeline Updates 2025 revenue guidance   Conference call begins today at 4:30pm Eastern time   BURLINGTON, Mass. (August 11, 2025) – Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company […]

The post Myomo Reports Second Quarter 2025 Financial and Operating Results appeared first on Myomo.

]]> Myomo Reports Second Quarter 2025 Financial and Operating Results

 

Revenue of $9.7 million

 816 patients added to the MyoPro pipeline

Updates 2025 revenue guidance

 

Conference call begins today at 4:30pm Eastern time

 

BURLINGTON, Mass. (August 11, 2025) – Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today reported financial results for the three and six months ended June 30, 2025.

Financial and operating highlights for the second quarter of 2025 include the following (all comparisons are with the second quarter of 2024 unless otherwise indicated): Read more.

The post Myomo Reports Second Quarter 2025 Financial and Operating Results appeared first on Myomo.

]]> https://myomo.com/myomo-reports-second-quarter-2025-financial-and-operating-results/feed/ 0